Evidence map›Paper›PMID 40401184›Full record

ArticleJGH open : an open access journal of gastroenterology and hepatology2025

History of Previous Medication Self-Discontinuation Predicts the Current Adherence to 5-Aminosalicylates in Patients With Ulcerative Colitis.

Shogo Kitahata, Ayaka Nakamura, Yuka Kimura, Mai Fukumoto, Kana Matsuoka, Takuya Matsuda, Kazuya Murakawa, Taisei Murakami, Kei Onishi, Hirofumi Izumoto and 15 more

Abstract read
In one paragraph

Article in JGH open : an open access journal of gastroenterology and hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Shogo KitahataGastroenterology Center Ehime Prefectural Central Hospital Matsuyama Ehime Japan.ORCID https://orcid.org/0000-0003-2133-6569
Ayaka NakamuraGastroenterology Center Ehime Prefectural Central Hospital Matsuyama Ehime Japan.
Yuka KimuraGastroenterology Center Ehime Prefectural Central Hospital Matsuyama Ehime Japan.
Mai FukumotoGastroenterology Center Ehime Prefectural Central Hospital Matsuyama Ehime Japan.
Kana MatsuokaGastroenterology Center Ehime Prefectural Central Hospital Matsuyama Ehime Japan.
Takuya MatsudaGastroenterology Center Ehime Prefectural Central Hospital Matsuyama Ehime Japan.
Kazuya MurakawaGastroenterology Center Ehime Prefectural Central Hospital Matsuyama Ehime Japan.
Taisei MurakamiGastroenterology Center Ehime Prefectural Central Hospital Matsuyama Ehime Japan.
Kei OnishiGastroenterology Center Ehime Prefectural Central Hospital Matsuyama Ehime Japan.
Hirofumi IzumotoGastroenterology Center Ehime Prefectural Central Hospital Matsuyama Ehime Japan.
Kozue Kanemitsu-OkadaGastroenterology Center Ehime Prefectural Central Hospital Matsuyama Ehime Japan.
Tomoe KawamuraGastroenterology Center Ehime Prefectural Central Hospital Matsuyama Ehime Japan.
Taira KurodaGastroenterology Center Ehime Prefectural Central Hospital Matsuyama Ehime Japan.
Junko MatsuokaGastroenterology Center Ehime Prefectural Central Hospital Matsuyama Ehime Japan.
Fujimasa TadaGastroenterology Center Ehime Prefectural Central Hospital Matsuyama Ehime Japan.
Hideki MiyataGastroenterology Center Ehime Prefectural Central Hospital Matsuyama Ehime Japan.
Atsushi HiraokaGastroenterology Center Ehime Prefectural Central Hospital Matsuyama Ehime Japan.
Kazuhiro TangeDepartment of Inflammatory Bowel Diseases and Therapeutics Ehime University Graduate School of Medicine Matsuyama Ehime Japan.
Yasunori YamamotoEndoscopy Center, Ehime University Graduate School of Medicine Matsuyama Ehime Japan.
Eiji TakeshitaDepartment of Inflammatory Bowel Diseases and Therapeutics Ehime University Graduate School of Medicine Matsuyama Ehime Japan.
Yoshiou IkedaEndoscopy Center, Ehime University Graduate School of Medicine Matsuyama Ehime Japan.
Shinya FurukawaHealth Services Center, Ehime University Matsuyama Ehime Japan.
Eiji TsubouchiGastroenterology Center Ehime Prefectural Central Hospital Matsuyama Ehime Japan.
Tomoyuki NinomiyaGastroenterology Center Ehime Prefectural Central Hospital Matsuyama Ehime Japan.
Yoichi HiasaDepartment of Gastroenterology and Metabology Ehime University Graduate School of Medicine Matsuyama Ehime Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: Medication adherence is critical in 5-aminosalicylate therapy for patients with ulcerative colitis. Patients with a history of previous medication self-discontinuation may continue to have low adherence due to the influence of inappropriate disease awareness. This study aimed to determine the association between the history of previous medication self-discontinuation and current adherence to 5-aminosalicylates in patients with ulcerative colitis. Methods and Results: This cross-sectional study was conducted in Japan from 2021 to 2024. A self-administered questionnaire was used in 228 patients with ulcerative colitis who were taking 5-aminosalicylates. We defined adherence as consumption of ≥ 80% of the prescribed dose. Patients with a history of previous medication self-discontinuation were defined as having discontinued medication at least once in the past by their own judgment. The current adherence rate to 5-aminosalicylates in this study was 92.9% (212/228). The proportion of patients with a history of previous medication self-discontinuation was 7.8% (18/228). History of previous medication self-discontinuation ( Conclusion: History of previous medication self-discontinuation was inversely associated with current adherence to 5-aminosalicylates among patients with ulcerative colitis. The results of this study suggest that determining the history of previous medication self-discontinuation may be a valuable tool in assessing current adherence to 5-aminosalicylates, which can be cumbersome.

Indexed as

5‐aminosalicylatesadherenceulcerative colitis

Identifiers

PMID40401184
PMCPMC12092371

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.